Profile
Mr. Bing Han is an Analyst at Athyrium Capital Management LLC.
Prior to joining Athyrium in 2012, Mr. Han was an investment banking analyst in the Leverage Finance group at Deutsche Bank.
In that capacity, Mr. Han worked on a number of debt transactions involving leveraged buyouts, acquisitions, refinancings and restructurings across multiple sectors.
Mr. Han graduated with an A.B. in Chemistry from Harvard College in 2011.
Former positions of Bing Han
| Companies | Position | End |
|---|---|---|
Deutsche Bank Corp.
Deutsche Bank Corp. Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank Corp. is a company based in New York, NY. | Corporate Officer/Principal | 2011-12-30 |
Athyrium Capital Management LP
Athyrium Capital Management LP Investment ManagersFinance Athyrium specializes in the healthcare sector and is primarily focused on longer-term investments including private equity, public equity and structured investments. Structured investments are investments composed of one or more of the following instruments: convertibles, loans, bonds, preferred stock, common stock, warrants, and royalties. The firm most typically employs a fundamental buy and hold strategy. Their approach to analysis is typically private equity-like in nature and includes sourcing, due diligence, structuring and negotiating transactions, and actively monitoring portfolio investments. | Analyst-Equity | - |
Training of Bing Han
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deutsche Bank Corp.
Deutsche Bank Corp. Regional BanksFinance Part of Deutsche Bank AG, Deutsche Bank Corp. is a company based in New York, NY. | Finance |
Athyrium Capital Management LP
Athyrium Capital Management LP Investment ManagersFinance Athyrium specializes in the healthcare sector and is primarily focused on longer-term investments including private equity, public equity and structured investments. Structured investments are investments composed of one or more of the following instruments: convertibles, loans, bonds, preferred stock, common stock, warrants, and royalties. The firm most typically employs a fundamental buy and hold strategy. Their approach to analysis is typically private equity-like in nature and includes sourcing, due diligence, structuring and negotiating transactions, and actively monitoring portfolio investments. | Finance |
- Stock Market
- Insiders
- Bing Han
















